Kunming Longjin Pharmaceutical Co.,Ltd. Posted 8.4 Million Yuan Net Loss in First Three Quarters of 2022

Kunming Longjin Pharmaceutical Co.,Ltd. (昆明龙津药业股份有限公司) (002750.SZ) reported a net loss of 8.4 million yuan in the first three quarters of 2022, reversing a net profit of 3.3 million yuan for the same period in the previous year.

Meanwhile, the company posted 102.8 million yuan in revenue, down 82.7% year-on-year.

At the end of the reporting period, it had 803 million yuan in total assets and 133.2 million yuan in total liabilities, with a liability-to-asset ratio of 16.6%.